Lee and Company dba Lee Pharmacy, Inc.
FDA inspection history in Fort Smith, Arkansas, 2013 to 2014
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2013: one Form 483; 2014: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2013–14One Form 483 and one warning letter, at Fort Smith, Arkansas.
Cited most
Across all Lee and Company dba Lee Pharmacy observations on file
- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.166Stability testing1
- 21 CFR 211.42Design and construction features1
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
The complete Lee and Company dba Lee Pharmacy file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Fort Smith, Arkansas
One warning letter and one Form 483 · 2013 to 2014 · 7 observations
Latest: Warning letter, Jun 6, 2014 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2014-06-06 | Warning letter Warning letter | Fort Smith, Arkansas | — | $99 |
| 2013-02-21 | 483 Form 483 | Fort Smith, Arkansas | 7 | $99 |
Investigators on these documents
FEI number 3002596670 · most recent document Jun 6, 2014
About Lee and Company dba Lee Pharmacy, Inc.
How many FDA Form 483s has Lee and Company dba Lee Pharmacy, Inc. received?
FDA Intel has 1 Form 483 on file for Lee and Company dba Lee Pharmacy, Inc.; the most recent is dated Feb 21, 2013.
When was Lee and Company dba Lee Pharmacy, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Lee and Company dba Lee Pharmacy, Inc. is a Form 483 dated Feb 21, 2013, for the site in Fort Smith, Arkansas.
What did FDA cite at Lee and Company dba Lee Pharmacy, Inc.?
The regulations cited most in the observations on file for Lee and Company dba Lee Pharmacy, Inc. are 21 CFR 211.100 (Written procedures; deviations), 2 times; 21 CFR 211.113 (Control of microbiological contamination), 2 times; 21 CFR 211.166 (Stability testing), 1 time.
Has Lee and Company dba Lee Pharmacy, Inc. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Lee and Company dba Lee Pharmacy, Inc.; the most recent is dated Jun 6, 2014.